SAFETY, TOLERABILITY, AND BIOLOGICAL ACTIVITY OF AXA1125 AND AXA1957 IN A PROSPECTIVE 16-WEEK RANDOMIZED, PLACEBO-CONTROLLED STUDY IN SUBJECTS WITH NAFLD WITH AND WITHOUT TYPE 2 DIABETES

被引：0

作者：

Harrison, Stephen A. ^{[1
]}

Gunn, Nadege T. ^{[2
]}

Baum, Seth J. ^{[3
]}

Younes, Ziad H. ^{[4
]}

Kohli, Anita ^{[5
]}

Patil, Rashmee ^{[6
]}

Koziel, Margaret J. ^{[7
]}

Chera, Harinder ^{[7
]}

Zhao, Jeff ^{[7
]}

Chakravarthy, Manu V. ^{[7
]}

机构：

[1] Pinnacle Clin Res Ctr, San Antonio, TX USA

[2] Pinnacle Clin Res, San Antonio, TX USA

[3] Excel Med Clin Trials, Boca Raton, FL USA

[4] Gastro One, Germantown, TN USA

[5] Arizona Liver Hlth, Chandler, AZ USA

[6] South Texas Res Inst, Edinburg, TX USA

[7] Axcella Hlth Inc, Cambridge, MA USA

来源：

HEPATOLOGY | 2020年 / 72卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

1694

引用

页码：1032 / 1033

页数：2

共 44 条

[41] A phase 2a, randomized, double-blind, placebo-controlled, three-arm, parallel-group study to assess the efficacy, safety, tolerability and pharmacodynamics of PF-06835919 in patients with non-alcoholic fatty liver disease and type 2 diabetes
Saxena, Aditi R.
Lyle, Stephanie-An
Khavandi, Kaivan
Qiu, Ruolun
Whitlock, Mark
Esler, William P.
Kim, Albert M.
DIABETES OBESITY & METABOLISM, 2023, 25 (04): : 992 - 1001
[42] Efficacy and Safety of Herbal Formulation Rich in Standardized Fenugreek Seed Extract as Add-on Supplementation in Patients with Type 2 Diabetes Mellitus on Sulfonylurea Therapy: A 12-week, Randomized, Double-blind, Placebo-controlled, Multi-center Study
Kandhare, Amit D.
Rais, Nadeem
Moulick, Nivedita
Deshpande, Alaka
Thakurdesai, Prasad
Bhaskaran, Sunil
PHARMACOGNOSY MAGAZINE, 2018, 14 (57) : S393 - S402
[43] Efficacy and safety of once-weekly glucagon-like peptide 1 receptor agonist albiglutide (HARMONY 1 trial): 52-week primary endpoint results from a randomized, double-blind, placebo-controlled trial in patients with type 2 diabetes mellitus not controlled on pioglitazone, with or without metformin
Reusch, J.
Stewart, M. W.
Perkins, C. M.
Cirkel, D. T.
Ye, J.
Perry, C. R.
Reinhardt, R. R.
Bode, B. W.
DIABETES OBESITY & METABOLISM, 2014, 16 (12): : 1257 - 1264
[44] Efficacy and tolerability of tirzepatide, a dual glucose-dependent insulinotropic peptide and glucagon-like peptide-1 receptor agonist in patients with type 2 diabetes: A 12-week, randomized, double-blind, placebo-controlled study to evaluate different dose-escalation regimens
Frias, Juan Pablo
Nauck, Michael A.
Van, Joanna
Benson, Charles
Bray, Ross
Cui, Xuewei
Milicevic, Zvonko
Urva, Shweta
Haupt, Axel
Robins, Deborah A.
DIABETES OBESITY & METABOLISM, 2020, 22 (06): : 938 - 946

← 1 2 3 4 5 →